PMID: 15346097Sep 4, 2004Paper

Improving the pharmacological regimen for patients with diabetes mellitus

Reviews in Cardiovascular Medicine
Steven P Marso

Abstract

Type 2 diabetes mellitus affects nearly 17 million people in the United States, and prevalence rates are expected to double within 2 decades. Although there has been a downward trend in cardiovascular morbidity and mortality in recent years, cardiovascular disease remains the leading cause of death among patients with diabetes. This observation had led many to reevaluate current treatment goals and pharmacologic regimens for at-risk patients with type 2 diabetes mellitus. This review focuses on the current adjunctive pharmacologic treatment regimen that is well-suited for these patients.

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Journal of the American College of Cardiology
Steven P Marso
Zhonghua er ke za zhi. Chinese journal of pediatrics
Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, Capital Institute of Pediatrics
The Canadian Child and Adolescent Psychiatry Review = La Revue Canadienne De Psychiatrie De L'enfant Et De L'adolescent
Candice L OdgersN Dickon Reppucci
© 2021 Meta ULC. All rights reserved